Casey Kim (@caseyjkim) header
Casey Kim (@caseyjkim) profile picture

Heme Onc Fellow at Tufts via @BIDMC_IM & @PennMedicine | MedEd | Clinical Reasoning | Trying to learn how to be a better person, doctor, and plant mom 🩺🪴

Joined July 2022
Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)Photo by Casey Kim (@caseyjkim)
1/ 🚨 NEW #5Pearls: Neutropenia 🦠 Let’s review the what, when, and why of neutropenia, including management of febrile neutropenia 🥵 🖥️: coreimpodcast.com/2025/08/13…
2
55
1
263
24,213
“How much time do I have left?” As an oncology hospitalist, this is the most common ? I hear from my patients. An interesting paper just came out in JCO using Machine Learning to predict mortality for geriatric oncology patients: ascopubs.org/doi/full/10.120… My thoughts 👇
1
1
226
CRP:Albumin ratio was also highlighted as a key predictive factor. Easy to get or include with monitoring labs for patients getting treatment. The only issue is on its own, seems to have fairly mild predictive effect (as estimated in the Cox proportional hazards method)
1
115
Still, a cool paper. I think it shows: - Further dev/integration of AI predictive models for personalized medicine in Oncology - Modeling to help better ID which patients could benefit from earlier palliative care/geriatrics As pt live longer w/ cancer, this will only 📈
104
It's flu season, so that means it's also COPD exacerbation season in the hospital. I always got a little confused as to what to do with all of their inhalers, but the gist is: - Continue their long acting inhalers - Duonebs will cover their rescue inhalers #MedTwitter
2
10
1,163
One of the hardest things I do in #oncology clinic is translate results from a clinical trial to the #patient in front of me. In @NatureMedicine, we introduce TrialTranslator, a #machinelearning framework for individualized #cancer trial emulation. nature.com/articles/s41591-0…
393
137
11
492
59,139
I took care of a patient with lung cancer who went to the ICU for respiratory failure of unclear etiology. CT chest done that suggested “lymphangitic carcinomatosis” Though he got better, that dx changed what happened next for him A 🧵 on lymphangitic carcinomatosis
2
5
6
1,640
The data is not great on prognosis (only case series b4 2000s), but roughly 2-7 months. Even patients with resectable lung cancer (so not metastatic) had earlier mortality by about 2 years if they had positive post op cancer in lymphatics than those who did not
1
1
179
Back to our pt, after the scan showed likely LC, he decided to stop tx and go home with hospice. If time was short, he wanted to spend with family, not healthcare system My take away point: Dx of LC can ground prognosis/time (months) for patients to help guide goals of care
1
163
Ever wonder if a certain symptom your patient with cancer is endorsing is related to their chemotherapy? The short answer is usually "maybe", but here's a helpful chart of common toxicities by chemotherapy classes. From hemeoncnotes.com, the solid cancer intro lecture!
1
3
208
"Tissue is the issue" For new pts admitted for new malignancy w/u, almost universally, the next ? is “is the biopsy done?” Seems obvious, but choosing when and where to biopsy has some nuance and directly impacts time to dx and tx A 🧵 on biopsy tips and tricks: #MedTwitter
2
10
19
2,309
6/ Cancer of unknown primary Path can show "carcinoma of unknown primary” The cancer is so undifferentiated, there are no specific tissue markers. Repeat biopsy usually not helpful unless you don’t have enough tissue to run molecular/genetic studies. ascopubs.org/doi/10.1200/OA-…
1
3
200
7/ For more tips on biopsies and a general introduction to solid cancers, check out the Solid Cancers Introductory Lecture [Residents] on hemeoncnotes.com
4
142